IP Library Granted Patent US 7,579,366
Granted Patent B2
US 7,579,366 · App. 10/386,999 · Granted Aug 25, 2009

Epothilone derivatives and their synthesis and use

Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,579,366
App. No.
10/386,999
Granted
Aug 25, 2009
Kind
B2
Abstract

The invention relates to epothilone analog represented by the formula I wherein (i) R 2 is absent or oxygen; “a” can be either a single or double bond; “b” can be either absent or a single bond; and “c” can be either absent or a single bond, with the proviso that if R 2 is oxygen then “b” and “c” are both a single bond and “a” is a single bond; if R 2 is absent then “b” and “c” are absent and “a” is a double bond; and if “a” is a double bond, then R 2 , “b” and “c” are absent; R 3 is a radical selected from the group consisting of hydrogen; lower alkyl; —CH═CH 2 ; —C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH; —CH 2 —O—(C 1 -C 6 -alkyl); and —CH 2 —S—(C 1 -C 6 -alkyl); R 4 and R 5 are independently selected from hydrogen, methyl or a protecting group; and R 1 is as defined in the specification, or a salt of a compound of the formula I where a salt-forming group is present. A further aspect of the invention is related to the synthesis of epothilone E. These compounds have inter alia microtubuli depolymerisation inhibiting activity and are e.g. useful against proliferative diseases.

Claims (30)

1. A compound represented by the following structure:

wherein

the waved bond indicates that bond “a” is present either in the cis or in the trans form;

(i) R 3 is a radical selected from the group consisting of hydrogen; lower alkyl (C 1 -C 6 );

—CH═CH 2 ; —C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH; —CH 2 —O—(C 1 -C 6 alkyl); and —CH 2 —S—(C 1 -C 6 alkyl);

R 4 and R 5 are independently selected from the group consisting of hydrogen, methyl, and a hydroxyl protecting group; and

R 1 is a radical selected from the following structures:

(ii) and, if R 3 is —CH═CH 2 ; C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH;

—CH 2 —O—(C 1 -C 6 alkyl); and —CH 2 —S—(C 1 -C 6 alkyl); and the other symbols except R 1 have the same meanings given above, R 1 can also be a radical selected from the following structures:

(iii)and, if R 3 is —CH═CH 2 ; C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH;

—CH 2 —O—(C 1 -C 6 alkyl); and —CH 2 —S—(C 1 -C 6 alkyl); and the other symbols except R 1 have the same meanings given above under (i), R 1 can also be a moiety of the formula

or a salt thereof where one or more salt-forming groups are present.

2. A compound of the formula I according to claim 1 wherein:

(i) R 3 is a radical selected from the group consisting of hydrogen; lower alkyl (C 1 -C 6 );

—CH═CH 2 ; C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH; —CH 2 —O—(C 1 -C 6 alkyl); and —CH 2 —S—(C 1 -C 6 alkyl);

R 4 and R 5 are independently selected from the group consisting of hydrogen, methyl, and a protecting group; and

R 1 is a radical selected from the following structures:

or a salt thereof where one or more salt-forming groups are present.

3. A compound of the formula I according to claim 1 wherein:

(i) R 3 is a radical selected from the group consisting of hydrogen; lower alkyl (C 1 -C 6 );

—CH═CH 2 ; C≡CH; —CH 2 F; —CH 2 Cl; —CH 2 —OH; —CH 2 —O—(C 1 -C 6 alkyl); and —CH 2 —S—(C 1 -C 6 alkyl);

R 4 and R 5 are independently selected from the group consisting of hydrogen, methyl, and a protecting group; and

R 1 is a radical selected from the following structure:

or a salt thereof where one or more salt-forming groups are present.

4. A compound according to claim 1 , selected from the group consisting of a compound of the following formulae:

or a salt thereof where one or more salt-forming groups are present.

5. A compound represented by the following structure:

wherein:

A is selected from the group consisting of methoxy, methylthio and ethenyl; and

D is selected from the group consisting of fluoro, and hydroxy.

Assignments (1)
CONFIRMATORY LICENSE Recorded Dec 20, 2017
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044919/0834 →
Continuity (3)
Division 0972007000
Continuation In Part 0910260200 · Jun 22, 1998
Related Publication 20030203938A1 · Oct 30, 2003